Trevigen announces the release of seven new coated well assay kits for cell adhesion studies.
A cell’s ability to adhere to extracellular matrix (ECM) proteins is a necessary precursor to cell invasion, and this process also modulates morphogenesis, wound healing, proliferation, differentiation, and survival. Researchers studying cancer cell behavior or developing cancer therapeutics study cell adhesion with various proteins, recognizing that manipulation of cell adhesion to the extracellular environment may significantly impact cell activities. What is desired then is an assay system providing a variety of ECM proteins in a quantitative, high throughput format.
Trevigen answers this need with a simple, standardized, high throughput adhesion assay format offering 96 well plates coated with Basement Membrane Extract, Laminin I, Collagen I, Collagen IV, Fibronectin, Vitronectin, or an array of all six ECM proteins. A black stripwell format minimizes background providing increased sensitivity. Calcein labeling allows direct comparison between the number of cells loaded and the number of cells that adhere, and additional controls are provided for determining background and non-specific binding.
Trevigen, Inc. focuses on the development, manufacturing and marketing of technology and products for cancer research, emphasizing apoptosis, DNA damage and repair, and cancer cell behavior.
Highly qualified ECM proteins are also available separately from Trevigen.
